Peter Maybarduk discusses COVID-19 vaccine ownership with LA Times columnist
By Michael Hiltzik
“‘One way we have considerably slowed the global timetable,’ says Peter Maybarduk, director of the Access to Medicines program at the advocacy group Public Citizen, ‘is by giving grants to companies and asking them to develop manufacturing arrangements that are in their interest rather than pooling resources and saying we’re going to teach the world how to make these vaccines and using all the available manufacturing capacity.’”
Read the full article here.